Abstract: In different embodiments of the present invention, systems, methods, and computer-readable storage media allow a user to analyze software application modules, during development of the software. The present invention may be used to analyze the software application modules, to identify vulnerabilities and to provide the user with actionable intelligence that may be used to improve the security of the software application modules. The actionable intelligence may include a list or groupings of the vulnerabilities ranked based on severability, type, and/or location.

Abstract: In different embodiments of the present invention, systems, methods, and computer-readable storage media allow a user to analyze software application modules, during development of the software. The present invention may be used to analyze the software application modules, to identify vulnerabilities and to provide the user with actionable intelligence that may be used to improve the security of the software application modules. The actionable intelligence may include a list or groupings of the vulnerabilities ranked based on severability, type, and/or location.

Abstract: A process for producing (R)-?-arylalanines is described. The process converts (S)-?-arylalanine to (R)-?-arylalanine using phenylalanine aminomutase and amino acid racemase. The (R)-?-arylalanine product can be used to form pharmaceutically useful drugs. Also disclosed are DNA sequences encloding phenylalanine aminomutase and amino acid racemase enzymes, sequences for PCR primers of the DNA sequences, and sequences for expressed aminomutase and amino acid racemase enzymes.

Abstract: Transacylase enzymes and the use of such enzymes to produce paclitaxel, related taxoids, as well as intermediates in the paclitaxel biosynthetic pathway are disclosed. Also disclosed are nucleic acid sequences encoding the transacylase enzymes.

Abstract: Transacylase enzymes of Taxus cuspidata and the use of such enzymes to produce Taxol™, related taxoids, as well as intermediates in the Taxol™ biosynthetic pathway are disclosed. Examples of specific enzymes described herein include taxadienol 5-O-acetyl transacylase (TAX1) and 10-deacetylbaccatin III-10-O-acetyl transferase (TAX6). Also disclosed are nucleic acid sequences encoding the T. cuspidata transacylase enzymes.

Abstract: Transacylase enzymes and the use of such enzymes to produce paclitaxel and related taxoids, as well as intermediates in the paclitaxel biosynthetic pathway, are disclosed. Also disclosed are nucleic acid sequences encoding such transacylase enzymes such as (but without limitation) C-13 phenylpropanoid side chain-CoA acyltransferase and benzoyl-CoA:3′-N-debenzoyl-2′-deoxytaxol N-benzoyltransferase.

Abstract: Transacylase enzymes and the use of such enzymes to produce paclitaxel and related taxoids, as well as intermediates in the paclitaxel biosynthetic pathway, are disclosed. Also disclosed are nucleic acid sequences encoding such transacylase enzymes such as (but without limitation) C-13 phenylpropanoid side chain-CoA acyltransferase and benzoyl-CoA:3′-N-debenzoyl-2′-deoxytaxol N-benzoyltransferase.

Abstract: Transacylase enzymes and the use of such enzymes to produce Taxol™, related taxoids, as well as intermediates in the Taxol™ biosynthetic pathway are disclosed. Also disclosed are nucleic acid sequences encoding the transacylase enzymes.

Abstract: Transacylase enzymes and the use of such enzymes to produce Taxol™, related taxoids, as well as intermediates in the Taxol™ biosynthetic pathway are disclosed. Also disclosed are nucleic acid sequences encoding the transacylase enzymes.

Abstract: Transacylase enzymes and the use of such enzymes to produce Taxol™, related taxoids, as well as intermediates in the Taxol™ biosynthetic pathway are disclosed. Also disclosed are nucleic acid sequences encoding the transacylase enzymes.